Kymera Therapeutics Inc
Kymera Therapeutics Inc (KYMR) Option Chain
As of September 23, 2026, Kymera Therapeutics Inc is trading at $115.47, a -5.40% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 56.0%. IV Rank is 21%.
Read more
Tracking the KYMR option chain helps you see every strike and expiry on Kymera Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Kymera Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of KYMR options activity at a glance. Use our scanner to monitor the KYMR option chain in real time and filter for the KYMR options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For KYMR stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the KYMR option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where KYMR stock options are being actively traded and where they are not.
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, general pustular psoriasis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors.
The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Kymera Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen KYMR options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of KYMR stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile44.44% Neutral
- Market cap (M$)9,601
- 52 weeks high-11.21%
- 52 weeks low125.92%
- Analyst recommendationStrong Buy
1.22 - Target price$138.64
20.07% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-03
- P/E—
- Future P/E—
- EPS (ttm)-3.24
- EPS growth next 5 years-12.58%
As of September 23, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 13.99 | 0 | 0 | 7.68 | 10.47 | 16.00 | 20.30 | 105.00 | -13.98 | — | 2.00 | 0.00 | 2.00 | 0 | 6 | 86.01 |
| 23.20 | 2 | 0 | 8.53 | 5.47 | 12.00 | 16.00 | 110.00 | -9.88 | 0.15 | 4.90 | 0.00 | 2.53 | 0 | 0 | 76.80 |
| 34.49 | 7 | 0 | 9.53 | 0.47 | 8.00 | 12.00 | 115.00 | -5.78 | 1.55 | 5.50 | 0.00 | 3.53 | 0 | 0 | 65.51 |
| 46.80 | 21 | 0 | 6.45 | 0.00 | 4.50 | 8.40 | 120.00 | -1.69 | 3.80 | 7.00 | 4.53 | 0.87 | 1 | 0 | 53.20 |
| 58.93 | 4 | 2 | 4.45 | 0.00 | 3.80 | 5.10 | 125.00 | +2.41 | 6.20 | 9.50 | 9.53 | -1.68 | 0 | 1 | 41.07 |
As of September 23, 2026
Scan the full option chain in one place
Browse the full KYMR option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→